Fate Therapeutics, Inc. short interest in 2023
In 2023, Fate Therapeutics, Inc.'s disclosed short interest ran from 15.90% of shares outstanding on 13 Jan 2023 to 10.70% on 29 Dec 2023, a change of -5.20 percentage points. The year's high was 29.92% on 15 Jun 2023 and its low 10.70% on 29 Dec 2023, averaging 21.38% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.51 days on 14 Jul 2023. Full history: Fate Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 15.90% (13 Jan 2023)
- End of year
- 10.70% (29 Dec 2023)
- Change
- -5.20 pp
- High
- 29.92% (15 Jun 2023)
- Low
- 10.70% (29 Dec 2023)
- Average
- 21.38%
- Highest days to cover
- 19.51 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 15.90% | 1.62 | |
| 31 Jan 2023 | 16.76% | 5.40 | |
| 15 Feb 2023 | 17.34% | 7.31 | |
| 28 Feb 2023 | 19.21% | 7.02 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 22.21% | 7.72 | |
| 31 Mar 2023 | 28.14% | 8.26 | |
| 14 Apr 2023 | 27.70% | 8.94 | |
| 28 Apr 2023 | 28.54% | 13.95 | |
| 15 May 2023 | 29.61% | 11.14 | 10-Q filed, results (8-K) |
| 31 May 2023 | 29.59% | 14.89 | |
| 15 Jun 2023 | 29.92% | 12.97 | |
| 30 Jun 2023 | 26.36% | 7.89 | |
| 14 Jul 2023 | 26.10% | 19.51 | |
| 31 Jul 2023 | 28.09% | 15.29 | |
| 15 Aug 2023 | 28.70% | 12.60 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 28.04% | 16.31 | |
| 15 Sep 2023 | 24.64% | 5.90 | |
| 29 Sep 2023 | 15.12% | 5.92 | |
| 13 Oct 2023 | 14.00% | 10.72 | |
| 31 Oct 2023 | 11.96% | 7.27 | |
| 15 Nov 2023 | 11.78% | 4.91 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 11.88% | 7.94 | |
| 15 Dec 2023 | 10.94% | 6.89 | |
| 29 Dec 2023 | 10.70% | 5.26 |
See also: Fate Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.